Y. Ko
Impact in
-
- Lung Cancer Research Studies
- Pancreatic and Hepatic Oncology Research
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
Papers in
- Oncology 6
- Lung Cancer Research Studies 2
-
- Epigenetics and DNA Methylation 2
- Glutathione Transferases and Polymorphisms 2
- Co-authors
- Volker Harth (3 shared papers)Josef Abel (2 shared papers)H. J. Biersack (1 shared paper)Hans H. Schild (1 shared paper)Samer Ezziddin (1 shared paper)Thomas Gerhardt (1 shared paper)Uwe-Jochen Göhring (1 shared paper)Α. Türler (1 shared paper)
- Journals
- Annals of Oncology (4 papers)British Journal of Cancer (2 papers)Occupational and Environmental Medicine (1 paper)Clinical Pharmacology & Therapeutics (1 paper)Journal of Hepatology (1 paper)
- Partner nations
- GermanySouth KoreaEthiopia
In The Last Decade
Y. Ko
12 papers receiving 496 citations
Peers
Comparison fields: 5 of 57
- Oncology 172
- Pharmacology 50
- Radiology, Nuclear Medicine and Imaging 98
- Pulmonary and Respiratory Medicine 136
- Cancer Research 54
Countries citing papers authored by Y. Ko
This map shows the geographic impact of Y. Ko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y. Ko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y. Ko more than expected).
Fields of papers citing papers by Y. Ko
This network shows the impact of papers produced by Y. Ko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y. Ko. The network helps show where Y. Ko may publish in the future.
Co-authors
The 25 scholars most cited alongside Y. Ko, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 146 | |
| 2 | Association of CYP1B1 codon 432 mutant allele in head and neck squamous cell cancer is reflected by somatic mutations of p53 in tumor tissue. | 2001 | 103 |
| 3 | 2009 | 73 | |
| 4 | 2003 | 69 | |
| 5 | 2007 | 60 | |
| 6 | 2005 | 51 | |
| 7 | 2024 | 3 | |
| 8 | 2007 | 1 | |
| 9 | 2014 | 1 | |
| 10 | 2013 | 1 | |
| 11 | 2014 | 1 | |
| 12 | 2008 | 1 | |
| 13 | 2025 | 0 |
About Y. Ko
Y. Ko is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Genetics and Pharmacology, having authored 13 papers that have together received 510 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (2 papers), Lung Cancer Research Studies (2 papers), Brain Metastases and Treatment (2 papers), Lung Cancer Treatments and Mutations (2 papers), Glioma Diagnosis and Treatment (2 papers), Glutathione Transferases and Polymorphisms (2 papers), Pharmacogenetics and Drug Metabolism (1 paper) and Circadian rhythm and melatonin (1 paper). The work is most often cited by research in Oncology (172 citations), Pharmacology (50 citations), Radiology, Nuclear Medicine and Imaging (98 citations), Pulmonary and Respiratory Medicine (136 citations) and Cancer Research (54 citations). Y. Ko has collaborated with scholars based in Germany, South Korea and Ethiopia. Frequent co-authors include Volker Harth, Josef Abel, H. J. Biersack, Hans H. Schild, Samer Ezziddin, Thomas Gerhardt, Uwe-Jochen Göhring, Α. Türler, Christian Marx and H. Palmedo. Their work appears in journals such as Annals of Oncology, British Journal of Cancer, Occupational and Environmental Medicine, Clinical Pharmacology & Therapeutics and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.